Research and Markets: Global Nanotechnology Drug Delivery Market Report 2013-2016: Market to Grow at a CAGR of 74 …

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/grcb6t/global) has announced the addition of the "Global Nanotechnology Drug Delivery Market 2012-2016" report to their offering.

IOTA NanoSolutions Ltd., Lena Nanoceutics Ltd., GlaxoSmithKline plc, Celgene Corp., and SkyePharma plc Dominate the Market

Global Nanotechnology Drug Delivery market to grow at a CAGR of 73.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R&D cost. The Global Nanotechnology Drug Delivery market has also been witnessing an increase in customer support services. However, the increasing safety concerns could pose a challenge to the growth of this market.

The other vendors mentioned in the report are Merck & Co. Inc., Pfizer Inc., AlphaRx Inc., Amgen Inc., Angiotech Pharmaceuticals Inc., Biophan Technologies Inc., Calando Pharmaceuticals Inc., Cephalon Inc., Cerulean Pharma Inc., Copernicus Therapeutics Inc., CritiTech Inc., CytImmune Sciences Inc., Elan Corp. plc, Debiotech SA, F. Hoffmann-La Roche Ltd., Nano Interface Technology Inc., Spherics Inc., Spectrum Pharmaceuticals Inc., SoluBest Ltd., Sigma-Tau Pharmaceuticals Inc., PharmaNova Inc., Particle Sciences Inc., Novavax Inc., Nanotherapeutics Inc., NanoSight Ltd., NanoCarrier Co. Ltd., NanoBioMagnetics Inc., Nano Interface Technology Inc., Merck Sharp & Dohme Corp., Kuecept Ltd., and Izon Science Ltd.

Key questions answered in this report:

- What will the market size be in 2016 and what will the growth rate be?

- What are the key market trends?

- What is driving this market?

- What are the challenges to market growth?

Go here to read the rest:

Research and Markets: Global Nanotechnology Drug Delivery Market Report 2013-2016: Market to Grow at a CAGR of 74 ...

Related Posts

Comments are closed.